Kodu・Aktsiate loetelu・OraSure Technologies Inc

OraSure Technologies Inc

Avatud

SektorTervishoid

3.87 2.65

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.69

Max

3.85

Põhinäitajad
By Trading Economics
Sissetulek	29M 6.2M
Müük	2.7M 31M
Aktsiakasum	-0.23
Kasumimarginaal	20.396
Töötajad	500
EBITDA	25M 4.3M

Dividendid
By Acuity
Järgmine tulemuste avaldamine	4. nov 2026

Turustatistika
By TradingEconomics
Turukapital	-24M 263M
Eelmine avamishind	1.22
Eelmine sulgemishind	3.87

Uudiste sentiment

By Acuity

91%

12 / 340 Pingereas Healthcare

OraSure Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. aug 2026, 19:26 UTC

OraSure Technologies is trading roughly flat as no specific news emerged during Thursday's session. The asset remains significantly below its 20-day moving average.

18. aug 2026, 20:06 UTC

OraSure Technologies Inc shares are lower today, continuing a downward trend since Monday. The stock is trading significantly below its 20-day moving average.

17. aug 2026, 19:36 UTC

OraSure Technologies Inc is declining today, influenced by a drop in the Health Care Supplies sub-sector. The stock remains below its 20-day moving average.

14. aug 2026, 19:51 UTC

OraSure Technologies Inc. shares are lower amid broader market declines following a surprise drop in U.S. retail sales for July.

13. aug 2026, 20:02 UTC

OraSure Technologies Inc is higher during Thursday's session, recovering from three consecutive declines. No specific company news has been identified to explain the movement.

12. aug 2026, 20:01 UTC

OraSure Technologies Inc shares are lower today, continuing a decline since Tuesday's close. No specific news was identified to explain the drop.

11. aug 2026, 19:46 UTC

OraSure Technologies Inc shares are lower today, continuing a downward trend since Monday's close amid broader market influences from recent economic data.

10. aug 2026, 19:56 UTC

News

OraSure Technologies reported second-quarter revenue of $30.6 million, driven by public-health diagnostics. Shares are lower despite positive developments and improved gross margins.

7. aug 2026, 19:36 UTC

OraSure Technologies Inc is rising, supported by broader market momentum amid expectations for a pause in interest rate hikes following a weaker jobs report.

6. aug 2026, 20:03 UTC

News

OraSure Technologies reported Q2 earnings above guidance but announced a delay in FDA clearance for its InteliQuick CT/NG product, contributing to a decline in shares.

5. aug 2026, 20:06 UTC

OraSure Technologies Inc. shares are lower today, pulling back from earlier gains. The stock remains above its 20-day moving average despite the decline.

4. aug 2026, 20:02 UTC

OraSure Technologies Inc is rising amid broader market gains, supported by declining crude oil prices and positive comments on potential peace talks with Iran.

3. aug 2026, 20:07 UTC

OraSure Technologies Inc. is gaining today, rebounding from earlier session lows. The broader market also shows positive momentum, with the S&P 500 rising.

31. juuli 2026, 20:02 UTC

OraSure Technologies Inc. is trading higher amid overall market gains, despite no specific company news. Rising Treasury yields and crude oil prices contribute to inflation concerns.

30. juuli 2026, 18:46 UTC

OraSure Technologies Inc shares are higher today, though no specific news explains the movement. The stock remains near its one-month range low.

29. juuli 2026, 17:02 UTC

OraSure Technologies Inc is declining during Wednesday's session, trading well below its 20-day moving average and near the lower end of its one-month range.

28. juuli 2026, 19:26 UTC

OraSure Technologies Inc is trading higher today, reflecting a positive move since Monday. The stock remains below its 20-day moving average.

27. juuli 2026, 17:02 UTC

News

OraSure Technologies Inc shares are lower as analyst sentiment shifts. Wall Street Zen upgraded the stock, while Weiss Ratings downgraded its outlook.

24. juuli 2026, 20:02 UTC

OraSure Technologies Inc. shares are lower today, reflecting broader market trends, and remain below their 20-day moving average.

23. juuli 2026, 20:03 UTC

OraSure Technologies Inc is rising sharply during Thursday's session, reflecting notable volatility and a strong upward trend since Wednesday's close.

22. juuli 2026, 18:46 UTC

News

OraSure Technologies received FDA Emergency Use Authorization for its OraQuick Ebola 2.0 test. Shares are trading roughly flat since Tuesday's close.

21. juuli 2026, 22:02 UTC

News

OraSure Technologies received FDA Emergency Use Authorization for its OraQuick Ebola 2.0 Rapid Antigen Test. Shares are higher in after-market hours amid increased production plans.

Võrdlus sarnastega

Hinnamuutus

OraSure Technologies Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi OraSure Technologies Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

12 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.